Today: 9 June 2026
Browse Category

NASDAQ:MRUS 30 December 2025 - 8 May 2026

Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus

Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus

Genmab A/S shares fell 3.3% to $30.44 in New York after the company dropped further development of acasunlimab, a late-stage cancer drug, following a portfolio review. Genmab said the move does not affect its 2025 guidance and will focus on other pipeline drugs. The company also completed its acquisition of Merus N.V., paying $97 per share in a tender offer. Merus requested Nasdaq delist its stock after the merger.
Merus stock halted today as Genmab buyout closes: what happens to MRUS shares and the $97 cash payout

Merus stock halted today as Genmab buyout closes: what happens to MRUS shares and the $97 cash payout

Merus N.V. shares were halted Tuesday after Nasdaq confirmed Genmab’s $97-a-share cash acquisition closed, with trading set for suspension Dec. 31. Holders will receive $97 per share minus a $10.67 Dutch dividend withholding tax, leaving about $86.33 before any refund. Merus requested delisting, and two directors resigned as the merger became effective. Genmab’s U.S. shares fell about 2% in late-morning trading.
30 December 2025

Stock Market Today

  • Uranium Energy Shares Fall 17% on Larger Q3 Loss Despite New Production Start
    June 9, 2026, 4:11 PM EDT. Uranium Energy Corp shares fell 17% to $10.43 after reporting a fiscal third-quarter net loss of $52.3 million, up from $30.2 million a year earlier. The Texas-based uranium miner began production at its Burke Hollow project, using in-situ recovery (ISR), which extracts uranium by dissolving ore underground. The company ended the quarter with $794 million in liquid assets and no debt. Weak sales of purchased uranium inventory contributed to the loss, dropping gross profit from sales to $10 million from $24.5 million last year. CEO Amir Adnani highlighted ongoing challenges in uranium conversion, a key step for nuclear fuel production. Despite falling shares, UEC expects production to rise in the fourth quarter as new facilities at Burke Hollow and Christensen Ranch operate fully. Market uranium prices remained stable near $85.70 per pound.

Latest articles

Dow Edges Up 16 Points, Nasdaq Falls After Bell

Dow Edges Up 16 Points, Nasdaq Falls After Bell

9 June 2026
Tech stocks plunged, dragging the Nasdaq down 1.21% as investors dumped AI and chip shares ahead of key inflation data and after President Trump called for a U.S. response to Iran’s downing of a U.S. helicopter; the Dow edged up just 16 points as volatility spiked to its highest since April 7.
POET Technologies Shares Drop; AI Photonics Trade Faces Pressure

POET Technologies Shares Drop; AI Photonics Trade Faces Pressure

9 June 2026
POET Technologies plunged 13% to $10.65 as renewed class-action reminders and April’s Marvell/Celestial AI order cancellation kept legal and execution risks in focus, outweighing a $50 million Lumilens order and $400 million financing, while broader AI chip stocks also slumped.
Uranium Energy Drops 17% After Reporting Q3 Loss

Uranium Energy Drops 17% After Reporting Q3 Loss

9 June 2026
Uranium Energy shares plunged 17% to $10.43 after reporting a wider Q3 net loss of $52.3 million and no uranium inventory sales, overshadowing the start of production at Burke Hollow; heavy volume and a sharper drop than peers reflected investor concerns over execution risks and near-term earnings despite strong cash and no debt.
Go toTop